Simplicity Wealth’s Anika Therapeutics ANIK Stock Holding History

Simplicity Wealth’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$285K	Buy	+14,500	New	+$278K	0.01%	884

Other funds holding ANIK

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

PWMG

Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Simplicity Wealth's ANIK Position: Q3 2026 in Review

Simplicity Wealth opened a new position in Anika Therapeutics (ANIK) in Q3 2026: 14,500 shares worth $285K. The stake represents 0.01% of the portfolio and ranks #884 among its holdings.

19 funds tracked by Wall St. Rank hold ANIK as of Q3 2026.

Simplicity Wealth held 14,500 shares of Anika Therapeutics worth $285K as of Q3 2026.
Anika Therapeutics was a new Simplicity Wealth position in Q3 2026.
Anika Therapeutics made up 0.01% of Simplicity Wealth's portfolio in Q3 2026, its #884 holding.
19 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2026.

Based on Simplicity Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.